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Abstract
Precursor nisin is a model posttranslationally modified precursor lantibiotic that can be structurally divided into a leader
peptide sequence and a modifiable core peptide part. The nisin core peptide clearly plays an important role in the precursor
nisin – nisin modification enzymes interactions, since it has previously been shown that the construct containing only the
nisin leader sequence is not sufficient to pull-down the nisin modification enzymes NisB and NisC. Serines and threonines in
the core peptide part are the residues that NisB specifically dehydrates, and cysteines are the residues that NisC
stereospecifically couples to the dehydrated amino acids. Here, we demonstrate that increasing the number of negatively
charged residues in the core peptide part of precursor nisin, which are absent in wild-type nisin, does not abolish binding of
precursor nisin to the modification enzymes NisB and NisC, but dramatically decreases the antimicrobial potency of these
nisin mutants. An unnatural precursor nisin variant lacking all serines and threonines in the core peptide part and an
unnatural precursor nisin variant lacking all cysteines in the core peptide part still bind the nisin modification enzymes NisB
and NisC, suggesting that these residues are not essential for direct interactions with the nisin modification enzymes NisB
and NisC. These results are important for lantibiotic engineering studies.
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Introduction
Nisin is a prominent lantibiotic produced by some strains of
Lactococcus lactis. Lantibiotics form a class of ribosomally synthe-
sized antimicrobial peptides, highly active against Gram-positive
bacteria. The spread of multi-drug resistant bacteria is an alarming
issue, especially in view of the decreasing effectiveness of
conventional antibiotics. To tackle this problem, novel antimicro-
bial agents are urgently needed. Lantibiotics are very promising
candidates to replace conventional antibiotics. Their unique
characteristics include the presence of lanthionine and (methyl)-
lanthionine rings and a high stability upon heat or proteolytic
treatment [1,2]. Precursor nisin consists of an N-terminal leader
peptide sequence and a C-terminal modifiable core peptide part.
Dehydrated residues are introduced posttranslationally by NisB,
specifically into the core peptide part, through dehydration of
serines and threonines, yielding Dha (dehydroalanine) and Dhb
(dehydrobutyrine), respectively. Lanthionine and (methyl)lanthio-
nine rings are formed by intramolecular coupling of cysteines to
the dehydrated residues in a stereospecific manner by the cyclase
NisC. Fully modified precursor nisin is transported by a dedicated
ABC transporter, NisT, to the outside of the cell, where the
protease NisP cleaves off the leader, liberating active nisin [3,4].
Recently, a complex of nisin modification enzymes has been
isolated, consisting of NisB, NisC and NisT [5].
Dehydration and cyclization processes for class I and class II
lantibiotics have been shown to proceed from the N-terminal to
the C-terminal end [6,7] and an alternating mode of action
between NisB and NisC has been proposed [6,8]. Interestingly, in
contrast to class I and II lantibiotics, class III lantibiotics synthetase
LabKC has a C- to N-terminus processing mode [9].
Nisin exerts at least two modes of antimicrobial action: i) by
binding to lipid II, an essential intermediate for cell wall
biosynthesis, it inhibits cell wall synthesis [10,11]; and ii) by
forming pores in the cell membrane, it releases cellular constit-
uents [11]. Nuclear magnetic resonance studies performed with
nisin and lipid II in sodium dodecyl sulfate micelles demonstrated
that the rings A and B of nisin are important for the nisin-lipid II
interactions [12]. In particular, formation of two intermolecular
hydrogen bonds between Dhb2 (dehydrobutyrine) and Abu8 (a-
aminobutyric acid) of nisin and the pyrophosphate moiety of a
lipid II analog was demonstrated experimentally [13]. Moreover,
it was shown that the formation of intermolecular hydrogen bonds
and contact of nisin with the electronegative pyrophosphates of
lipid II triggers the formation of a cage-like structure, consisting of
rings A and B [13]. Due to sequestering of lipid II, nisin is active at
nM concentrations. Nisin additionally inhibits the outgrowth of
spores via lipid II-dependent pore formation [14]. Class I
lantibiotics possess two modification enzymes, i.e. a dehydratase
LanB and a cyclase LanC. Class II lantibiotics are modified by a
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bi-functional enzyme called LanM, which is able to perform both
the dehydration and the cyclization reactions. The C-terminal part
of LanM enzymes has a low sequence similarity to that of LanC
enzymes and is anticipated to perform the cyclization reaction.
However, the N-terminal part of LanM does not share any
homology with NisB. Applying various unnatural substrates, it has
been demonstrated that the class I NisBTC machinery as well as
the class II LanM enzymes can modify non-lantibiotic peptides, if
they N-terminally possess the class I nisin leader or a class II leader
[15–21]. Moreover, the class II LctM enzyme has been shown to
modify peptides where the core peptide and the leader peptide
parts are separated by several alanine residues and more
excitingly, peptides that had non-proteinogenic amino acids in
the leader or in the core peptide parts were also modified [18].
This suggests that lantibiotic modification enzymes have very
relaxed substrate specificities.
The nisin leader is an important site of interaction between
precursor nisin and the modification enzymes NisB and NisC
[5,22–25]. Furthermore, the class I and class II lantibiotics have
been observed to be (partially) modified in the absence of the
leader [20,22]. However, the core peptide part has also been
demonstrated to be involved in the interactions with NisB and
NisC [22]. This notion is important in the light of increased
interest to engineering of lantibiotics. What particular residues in
the core peptide are involved in the interactions with the nisin
modification enzymes NisB and NisC is not known.
Successful examples of the enhancement of the antimicrobial
activity of nisin by protein engineering exist [26,27]. Ring
engineering studies of nisin have demonstrated that to exert
antimicrobial activity, the thioether rings ABC of nisin should be
present [28]. Opening of ring A results in significant loss of
antimicrobial activity against Micrococcus luteus NCDO 8166 and
leads to a complete loss of antimicrobial activity against Lactococcus
lactis MG1614 [28]. Opening of ring B results in a lack of
antimicrobial activity against L. lactis LL108 [29]. Ring C has been
shown to be essential for nisin antimicrobial activity by a)
thermolysin cleavage of the Ala15-Leu16 and subsequently the
Leu16-Met17 bonds in ring C of nisin(1–29); b) introducing a
tryptic cleavage site into ring C by substituting the Met17 by Lys
and subsequent trypsin treatment [30]; c) engineering a disulfide
bond instead of a lanthionine that, upon reduction, caused a total
loss of activity [31].
Negatively charged amino acids are not naturally found in the
core peptide part of precursor nisin and closely related peptides
such as subtilin and epidermin [32]. The absence of negatively
charged amino acids in the core peptide region of precursor nisin
was intriguing to us and might be an indication that negatively
charged residues are unfavourable for the interactions with the
nisin modification machinery and/or for modification. Another
possibility is that negatively charged residues have a negative
impact on the antimicrobial activity of nisin. Which exact residues
in precursor nisin are involved in the interactions with the nisin
modification enzymes NisB and NisC is not known. The
development of a nisin binding assay [5] facilitates molecular
characterization of the interactions between precursor nisin and its
modification enzymes [5]. In this study, we perform co-purifica-
tion studies of the nisin modification enzymes NisB and NisC with
structurally unnatural precursor nisin molecules lacking modifiable
residues in the core peptide part as well as with mutants that have
various numbers of negatively charged residues in the core peptide
part, to investigate whether binding of the modifying enzymes to
precursor nisin and the substrate-enzyme complex formation are
hampered, and whether modifications can still occur.
Materials and Methods
Synthetic nisin variants
Synthetic DNA encoding nisin variants was ordered from Life
Technologies and subsequently cloned into a pNZnisAE3 vector
[15] through cutting out the nisA gene by utilizing BglII and
HindIII restriction sites, and cloning of the synthetic DNA,
encoding precursor nisin, using the same restriction sites.
Recombinant DNA techniques
Standard genetic manipulations were essentially performed as
described by Sambrook et al.[33]. Plasmid isolation was performed
by means of the Plasmid DNA Isolation Kit (Roche Applied
Science). Restriction analysis was performed with restriction
enzymes from Fermentas. DNA ligation was performed with T4
DNA ligase (Fermentas) and round PCR amplification was done
with Phusion DNA polymerase (Finnzymes).
Bacterial strains and growth conditions
Strain Lactococcus lactis NZ9000 [34] was used as an expression
host in this study. In short, cells were grown as described
previously [5] at 30uC in M17 medium (Difco) supplemented with
0.5% (w/v) glucose and 5 mg/ml chloramphenicol or 5 mg/ml
erythromycin where appropriate. In case both antibiotics were
used simultaneously, 4 mg/ml chloramphenicol and 4 mg/ml
erythromycin were applied.
Antimicrobial activity assay
The indicator strain L.lactis NZ9000 bearing plasmid pNZnisPT
was grown ON in M17 medium supplemented with 0.5% glucose.
Next morning it was re-inoculated into a fresh M17 medium
containing 0.5 ng/ml nisin for induction. When the OD600
reached 0.6, 100 ml of the culture was added to 100 ml of liquid
M17 agar at 40uC. Plates were dried, and wells were made. 50 ml
Ni-NTA purified samples were applied to the wells and the plates
were left ON at 30uC.
Ni-NTA purification
Ni-NTA purification was performed as previously described [5].
In brief, 1.5 ml of 50% superflow Ni-NTA column resin (Qiagen)
was equilibrated twice with 38.5 ml lysis buffer (50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8) in a 50 ml
tube by mixing on a rotor for 30 minutes. Subsequently, column
material was resuspended in a 4–8 ml cytoplasmic fraction,
transferred into a 15 ml tube, lysis buffer was added to a final
volume of 12 ml and histagged protein was allowed to bind to the
column material on a rotor in the cold room at 4uC for 2 hours.
Subsequently, the column was washed twice with 35 ml of wash
buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole,
pH 8). Elutions were collected in four fractions of 0.5 ml each with
elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM
imidazole, pH 8). Fractions were analyzed by SDS-PAGE and
Western Blot.
SDS-PAGE and Western Blot
Western blots were performed using anti-NisB, anti-NisC or
anti-leader antibodies [5]. SDS-PAGE was done using standard
molecular biology techniques [33]. Samples were not boiled before
applying to SDS-PAGE.
Results
In order to investigate the substrate specificity of the nisin
modification enzymes and to determine the binding requirements
Ser/Thr-Less and Cys-Less Precursor Nisin Variants
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of precursor nisin to the modification enzymes NisB and NisC, we
engineered two synthetic nisin variants, i.e. one lacking all serine
and threonine residues in the core peptide part, and a second one
lacking all cysteines. Additionally, precursor nisin variants with
increasing numbers of negatively charged amino acids were made
(Fig. 1; Table 1). A previously described prenisin interaction assay
was used that allows co-purification of the nisin modification
enzymes NisB and NisC using a precursor nisin with a C-terminal
His-tag extension as bait [5].
Ser/Thr-less and Cys-less variants of precursor nisin still
bind NisB and NisC
Unnatural precursor nisin variants, one lacking all serines/
threonines and another one lacking all cysteines (all these residues
were replaced by Ala residues) were expressed (Fig. 1) and
employed as substrates for in vivo modification. Both synthesized
variants were still able to bind NisB and NisC and able to pull
them down (Fig. 2A and 2C). This observation indicates that the
presence of serines and threonines in the core peptide part of
precursor nisin is not essential for NisB binding, and the presence
of cysteines is not absolutely necessary for NisB or NisC binding.
However, in the situation with Ser/Thr-less precursor nisin, only
NisC can be detected (Fig. 2C, lane 2) but not the complex of
NisB-NisA, as detected with Cys-less precursor nisin (Fig. 2C,
lane 1).
Negatively charged residues in the core peptide do not
influence NisB and NisC interactions
The requirements for binding of the nisin modification enzymes
NisB and NisC to precursor nisin are currently unknown. The
leader peptide is crucially important, but electrostatic interactions
with the core peptide might also have an influence. To investigate
this hypothesis, we introduced additional negative charges into the
core peptide part of precursor nisin (Fig. 1). Three variants of
precursor nisin with an increasing number of negatively charged
residues were made, namely NisA-H6 T2D P9D with two
negatively charged residues, NisA-H6 T2D P9D K12D N20E
with four negatively charged residues and NisA-H6 T2D P9D
K12D N20E H27D K34E with six negatively charged residues
(Fig. 1). These precursor nisin mutants were able to co-purify with
NisB, indicating binding to NisB (Fig. 2B).
Figure 1. Schematic drawing of precursor nisin NisA-H6 mutants with increasing numbers of negatively charged residues. (The
arrows indicate the residues that were substituted either by D (Asp) or E (Glu). Dehydrated Ser/Thr are depicted in orange, cysteines that that are
coupled to dehydroresidues are depicted in yellow.
doi:10.1371/journal.pone.0074890.g001
Table 1. Lactococcus lactis strains and plasmids used in this study.
Strain Characteristics References
NZ9000 nisRK [34]
Plasmids
pNZnisA-E3 nisA [15]
pNZnisA-H6 nisA, encoding precursor nisin NisA-H6, C-terminally extended with codons for
GSIEGRHHHHHH
[5]
pIL32BTC nisBTC, encoding nisin modification machinery this study
pNZnisA-H6 T2D P9D nisA encoding NisA-H6 with T2D P9D substitutions this study
pNZnisA-H6 T2D P9D K12D N20E nisA encoding NisA-H6 with T2D P9D K12D N20E substitutions this study
pNZnisA-H6 T2D P9D K12D N20E H27D K34E nisA encoding NisA-H6 with T2D P9D K12D N20E H27D K34E substitutions this study
pNZnisA-H6 T2A S3A S5A 8TA T13A T23A T25A S36A nisA encoding NisA-H6 with T2A S3A S5A 8TA T13A T23A T25A S36A substitutions
(Ser/Thr-less)
this study
pNZnisA-H6 C7A C11A C19A C26A C28A nisA encoding NisA-H6 with C7A C11A C19A C26A C28A substitutions (Cys-less) this study
doi:10.1371/journal.pone.0074890.t001
Ser/Thr-Less and Cys-Less Precursor Nisin Variants
PLOS ONE | www.plosone.org 3 September 2013 | Volume 8 | Issue 9 | e74890
Effect of negatively charged residues in the core peptide
on the antimicrobial activity of precursor nisin
Introduction of negatively charged residues at different positions
of the core peptide part of precursor nisin results in a severe
decrease in antimicrobial activity (Fig. 3). The notion that the
backbones of rings A and B interact with lipid II [13] and that the
C-terminal part of nisin is responsible for the interactions with the
lipid membrane [35] allows us to classify the substitutions into
categories: the T2D- lipid II interactions, the P9D- lipid II
interactions, the K12D- membrane interactions, the N20E-
membrane interactions, the H27D- membrane interactions, the
K34E- membrane interactions. The general trend that is observed
constitutes a severe decrease in the antimicrobial potency of nisin
with increasing numbers of negatively charged residues introduced
into the core peptide part.
Discussion
The substrate specificity of lantibiotic modification enzymes is
not yet well understood, although some rules for the posttransla-
tional modifications have been proposed [32]. Despite many
attempts, obtaining the crystal structure of NisB is still a challenge.
However, recently the long-awaited in vitro activity of NisB has
been successfully reconstituted [36] which will lead to a more
detailed understanding of the mechanism of NisB. In order to shed
more light on the substrate specificities of this interesting enzyme,
we made specific mutations in the core peptide part of precursor
nisin and analyzed these variants a) for binding with the nisin
modification enzymes NisB and NisC, b) for their antimicrobial
activity in case of negative charge altered mutants.
Although serines and threonines are the residues that NisB
specifically modifies, here we demonstrate that precursor nisin
lacking all serines and threonines in the core peptide part still
binds to and can co-purify NisB and NisC in the precursor nisin-
modification enzyme pull-down assay [5]. This suggests that the
serines and threonines are not involved in direct binding to NisB
and strengthens the notion that the leader peptide in particular has
the strongest contribution to modification enzyme binding.
Notably, the Cys-less precursor nisin pulls down both NisC and
the NisC-NisA complex, whereas the Ser/Thr-less precursor pulls
down only NisC. This may indicate the importance of cysteines in
precursor nisin for a release of NisA from NisC, i.e. the absence of
cysteines may lead to incomplete reactions and thus inefficient
release of NisA from NisC.
Our study demonstrates that the presence of increasing
numbers of negatively charged residues in the core peptide part
does not lead to decreased NisB-precursor nisin interactions either.
Notably, although negatively charged residues in the core peptide
part do not interfere with the binding of precursor nisin mutants to
the modification enzymes NisB and NisC, NisA-H6 T2D P9E,
NisA-H6 T2D P9E K12D N20E and NisA-H6 T2D P9E K12D
N20E H27D K34E mutants have strongly decreased antimicrobial
activity levels, demonstrating that the negatively charged residues
at positions T2, P9, K12, N20, H27 and K34 have an adverse
Figure 2. Co-purification assay of the nisin modification
enzymes NisB and NisC with different precursor nisin variants.
2A. SDS-PAGE analysis of co-purification assay of strains expressing wild
type enzymes NisBTC and: Lane 1: precursor nisin NisA-H6; Lane 2: Cys-
less precursor nisin (NisA-H6 C-less); lane 3: Ser/Thr-less precursor nisin
(NisA-H6-TS); Lane 4: empty vector (negative control). 2B. SDS-PAGE
analysis of co-purification assay of strains expressing wild type enzymes
NisBTC and: Lane 1: NisA-H6 T2D P9E; lane 2: NisA-H6 T2D P9E K12D
N20E; lane 3: NisA-H6 T2D P9E K12D N20E H27D K34E. 2C. Western blot
of co-purification assay of strains expressing wild type enzymes NisBTC
and precursor nisin variants. Co-purified NisC was detected by anti-NisC
antibodies. Lane 1: Cys-less precursor nisin (NisA-H6 C-less); lane 2: Ser/
Thr- less precursor nisin (NisA-H6 TS-less). The lower band represents
NisC, the upper band represents NisC in a complex with NisA.
doi:10.1371/journal.pone.0074890.g002
Figure 3. Antimicrobial activity assay of NisA-H6 variants
purified from strains expressing wild type enzymes NisBTC.
50 ml of Ni-NTA purified samples were applied to the wells in the agar
plate containing nisin sensitive indicator strain L.lactis NZ9000
expressing NisPT. Well A: empty plasmid pNZ8048E (negative control);
well B: wild type NisA-H6; well C: NisA-H6 T2D P9D with two negatively
charged residues; well D: NisA-H6 T2D P9D K12D N20E with four
negatively charged residues; well E: NisA-H6 T2D P9D K12D N20E H27D
K34E with six negatively charged residues. The presence of the halo
indicates the presence of active nisin processed by NisP to remove the
leader.
doi:10.1371/journal.pone.0074890.g003
Ser/Thr-Less and Cys-Less Precursor Nisin Variants
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effect on the antimicrobial activity of nisin. However, the observed
antimicrobial activity suggests the presence of at least three
lanthionine rings and indicates that these mutants are partially
dehydrated.
The C-terminal region of nisin is responsible for interactions
with the target membrane, in particular with negatively charged
lipids [35]. The nisin rings A and B are responsible for the
interactions with the pyrophosphates of lipid II [12,13]. Depend-
ing on the position, the decreased levels of the antimicrobial
activity of the nisin mutants containing negatively charged residues
in the core peptide part are probably due to a) decreased affinity
for the pyrophosphate moiety of lipid II (positions T2, P9), b)
decreased affinity for negatively charged phospholipids (positions
K12, N20, H27 and K34) and c) a lack of one or more lanthionine
rings. The first two thioether rings in nisin, i.e. ring A and B (Fig.
1) form a cage-like structure that interacts with the electronegative
pyrophosphate moiety of lipid II. The negatively charged residues
introduced in the N-terminal part of nisin, i.e. T2D P9D K12D
N20E, are highly likely to be unfavourable in terms of electrostatic
interactions with lipid II. Changing T to D at position 2 of nisin
results in a more bulky side chain. Most likely, in addition to the
unfavourable electrostatic effect, this leads to steric hindrance of
the altered cage-like structure with the pyrophosphate moiety. The
steric hindrance effect is also supported by the notion that
mutation of the adjacent residue, i.e. S3T leads to 12 fold-reduced
antimicrobial activity [30]. The Ser at position 3 is in the D-
configuration, and the decrease in the antimicrobial activity by
changing the thioether ring A from lanthionine to methyllanthio-
nine remained unexplained until NMR studies [13] demonstrated
that the additional methyl group would point in the space
surrounded by the cage structure of the rings. To the best of our
knowledge, the T2D substitution has never been studied before,
while the T2A, the T2S and the T2V single point nisin mutants
did not lead to a significant change in antimicrobial activity [37].
Our results show that the presence of negatively charged
residues in the C-terminus of NisA (NisA-H6 T2D P9D K12D
N20E H27D K34E mutant) further decreases the antimicrobial
activity of nisin (Fig. 3). This result is in agreement with previously
published data, where the nisin Z V32E mutant, containing an
extra negative charge, was analyzed for interactions with
negatively charged lipids and for its antimicrobial activity [35].
In this study, NisZ V32E was demonstrated to have a decreased
affinity towards negatively charged lipids together with a
concomitant decreased antimicrobial activity [35]. Our study
demonstrates a general trend that the increase in negative charges
in the nisin core part lowers the antimicrobial activity of the
mutants. With a few negative charges there should be at least three
lanthionine rings present because mutants with rings A, B and C
correctly formed are known to retain some activity. In case of high
numbers of negative charges we cannot exclude that multiple lack
of modification, as also suggested by Rink et al [32], is also
responsible for the negligible activity observed. However, the
substrate peptides can still be bound by NisBC. The presence of
negatively charged residues in the core peptide part of precursor
nisin lead to severely decreased antimicrobial activity of the nisin
mutants bearing negatively charged residues, either caused by
incomplete modification reactions or reduced interactions with
lipid II and/or membranes or both. Serines/threonines and
cysteines are not necessary for the interactions of the precursor
nisin core peptide with the nisin modification enzymes. These
findings can guide further engineering of lantibiotics as a potential
class of alternative antibiotics.
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